Results 291 to 300 of about 288,727 (306)

Drug–drug interactions in patients receiving tyrosine kinase inhibitors

Journal of Oncology Pharmacy Practice, 2018
Alison Duffy, James A Trovato
exaly  

Salicylanilides as inhibitors of the protein tyrosine kinase epidermal growth factor receptor

European Journal of Medicinal Chemistry, 2004
Guido Bold, Pascal Furet, Peter Traxler   +2 more
exaly  

Risk of tyrosine kinase inhibitors-induced hepatotoxicity in cancer patients: A meta-analysis

Cancer Treatment Reviews, 2013
Han Kiat Ho
exaly  

Are Tyrosine Kinase Inhibitors the Better Serotonin Inhibitors?

American Journal of Respiratory and Critical Care Medicine, 2013
Djuro, Kosanovic, Ralph, Schermuly
openaire   +2 more sources

Tyrosine Kinase Inhibitors

2008
openaire   +2 more sources

Tyrosine Kinase Inhibitors of Vascular Endothelial Growth Factor Receptors in Clinical Trials: Current Status and Future Directions

Oncologist, 2006
Alessandro Morabito, Massimo Di Maio, Nicola Normanno   +2 more
exaly  

Tyrosine Kinase Inhibitors Are Potent Acute Pulmonary Vasodilators in Rats

American Journal of Respiratory Cell and Molecular Biology, 2011
Kohtaro Abe, Abdallah Alzoubi, Karel Koubský   +2 more
exaly  

Tyrosine kinase inhibitors in cancer treatment (Part II)

Expert Opinion on Therapeutic Patents, 1998
Peter Traxler
exaly  

Strategies toward the Design of Novel and Selective Protein Tyrosine Kinase Inhibitors

1999
Peter Traxler, Pascal Furet, P Traxler   +2 more
exaly  

Novel approaches to the development of tyrosine kinase inhibitors and their role in the fight against cancer

Expert Opinion on Drug Discovery, 2014
Adriana Zàmečnikovà
exaly